Stephen J. Galli
CIK: 0001551951
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOS
ATOSSA THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About Galli Stephen J
Galli Stephen J (SEC CIK 0001551951) files insider reports with the SEC as Director of ATOSSA THERAPEUTICS, INC. (ATOS).
Signal8 holds 2 ownership filings by Galli Stephen J, all Form 4s, filed between May 16, 2025 and May 14, 2026. Those filings report 2 transactions, from May 15, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Galli Stephen J's filings is in SEATTLE, WA.
Recent filings by Galli Stephen J
Other insiders filing for ATOSSA THERAPEUTICS, INC. (ATOS)
- Steinhart Richard I, Director
- Chen Shu-Chih, Director
- Remmel H. Lawrence, Director
- Finn Jonathan, Director
- Cigler Tessa, Director
- Daniel Mark James, Chief Financial Officer